85.7% of ‘high ANGPTL4’ RA patients were RANKL-positive, compared with only 16.7% of ‘low ANGPTL4’ RA patients (p<0.05) and 20.0% of controls (p<0.01) (Figure 4C). This evidence concerns the gene ANGPTL4 and rheumatoid arthritis.